| Stats | Twitter歴 4,177日（2009/04/14より） |
ツイート数 70,217（16.8件/日） |
表示するツイート :
Naoto T Ueno, MD, PhD@teamoncology
Our review article"Targeting Signaling Pathways in Inflammatory Breast Cancer" was selected as the cover of the journal "Cancers." Very happy! Congrats to all authors, Xiaoping Wang, Takashi Semba, Lan Phi, Sudpreeda Chainitikun, Toshiaki Iwase, Bora Lim. #oncoalert https://pic.twitter.com/JPLq8Rybq2
posted at 20:32:23
Naoto T Ueno, MD, PhD@teamoncology
Naomi Osaka from Japan rallies for three-set win over Victoria Azarenka and her second US Open. Somehow people thinks that she is an American because of how she appears. Unconscious bias. title https://www.usatoday.com/story/sports/tennis/2020/09/12/naomi-osaka-victoria-azarenka-us-open-final/5781025002/… via @USATODAY
posted at 09:25:44
Naoto T Ueno, MD, PhD@teamoncology
Gilead near deal to buy Immunomedics for more than $20 billion. Wow, this will give Gilead the ADC linker technology that may increase the bandwidth of cancer drug development. #bcsm https://www.marketwatch.com/story/gilead-near-deal-to-buy-immunomedics-for-more-than-20-billion-2020-09-12?reflink=mw_share_twitter…
posted at 08:05:42
Naoto T Ueno, MD, PhD@teamoncology
Unconscious bias against cancer survivors can even happen by cancer center employees with plenty of cancer knowledge. Labeling how much you can work without directly asking the employees the question. :(
posted at 13:45:00
Naoto T Ueno, MD, PhD@teamoncology
Please join the IBC Wrangle to boot the inflammatory breast cancer. No donation required. Joining the team gives a statement that we want to get rid of IBC. #bcsm #endcancer https://secure3.convio.net/mdacc/site/TRR/Walk/BootWalk/717915433?pg=utype&fr_id=1341…
posted at 07:09:01
Naoto T Ueno, MD, PhD@teamoncology
Since April, I now know three people who passed away due to COVID-19 and one person who made through the ICU. It is just a sad feeling.
posted at 06:35:37
Naoto T Ueno, MD, PhD@teamoncology
@caseofdees In general, it is considered to be about 2 times higher than the general population. It is higher but standard monitoring such as yearly mammogram is sufficient.
posted at 05:40:34
Naoto T Ueno, MD, PhD@teamoncology
The most up-to-date review of the systemic treatment for newly diagnosed inflammatory breast cancer. #OncoAlert #Endcancer #bcsm
https://www.sciencedirect.com/science/article/pii/S2090123220302009…
posted at 05:38:51
Naoto T Ueno, MD, PhD@teamoncology
@caseofdees Please help me understand the question. Are you asking the risk of recurrence of contralateral breast cancer?
posted at 13:44:22
Naoto T Ueno, MD, PhD@teamoncology
@IBCNetworkUK We appreciate for sharing this important paper #OncoAlert
posted at 13:42:38
Naoto T Ueno, MD, PhD@teamoncology
Targeting Signaling Pathways in Inflammatory Breast Cancer. Summary of the latest biology update in IBC. https://www.mdpi.com/814912 via @MDPIOpenAccess #oncoalert
posted at 00:31:54
Naoto T Ueno, MD, PhD@teamoncology
Hand washing. Respect to elderly. Less obesity. Many factors contributed to one of the lowest mortality of the seniors by COVID-19 in the world. https://www.washingtonpost.com/world/asia_pacific/japan-coronavirus-elderly-death-rate/2020/08/29/f30f3ca8-e2da-11ea-82d8-5e55d47e90ca_story.html?outputType=amp…
posted at 04:09:55
Naoto T Ueno, MD, PhD@teamoncology
Link to our book "Inflammatory Breast Cancer: An Update" with #Springer http://www.springer.com/978-94-007-3906-2… via @SN_Authors
posted at 22:41:37
Naoto T Ueno, MD, PhD@teamoncology
I hope that he will get well from his ulcerative colitis. I hope that it is not colorectal cancer. The UC patients have a higher risk of developing cancer. https://twitter.com/nytimes/status/1299217050930491392…
posted at 15:40:50
Naoto T Ueno, MD, PhD@teamoncology
@united Both!!
posted at 08:01:28
Naoto T Ueno, MD, PhD@teamoncology
Dr Patrick Hwu @CancerMedMDA of @MDAndersonNews will be the next president of @MoffittNews. Congratulations. https://moffitt.org/newsroom/press-release-archive/2020/moffitt-cancer-center-names-patrick-hwu-md-as-president-and-ceo/… #endcancer
posted at 00:28:58
Naoto T Ueno, MD, PhD@teamoncology
The winner is? https://pic.twitter.com/Wrz5qbHooW
posted at 23:36:50
Naoto T Ueno, MD, PhD@teamoncology
Stress-reducing baby shark. https://www.youtube.com/watch?v=eGnTvvW0eN4…
posted at 21:44:53
Naoto T Ueno, MD, PhD@teamoncology
The lung sound of the severe COVID-19 patients by digital stethoscope. Fascinating.
https://youtu.be/Oa0u8c_tTQk
posted at 09:53:37
Naoto T Ueno, MD, PhD@teamoncology
@ACS_Research Thanks
posted at 19:31:17
Naoto T Ueno, MD, PhD@teamoncology
Surgical resection of breast cancer liver metastasis yielded higher overall survival compared with systemic therapy alone and prolonged PFS among patients with the HER2-enriched subtype. @MDAndersonNews experience of 899 cases. #bcsm #oncoalert https://authors.elsevier.com/c/1bZgI2gGSnuzvt#.XzXNMiKbQyI.twitter…
posted at 08:33:24
Naoto T Ueno, MD, PhD@teamoncology
Prediction of Bone Metastasis in Inflammatory Breast Cancer Using a Markov Chain Model. The paper shows how breast cancer spreads to different organs during the course of metastasis. #bcsm #OncoAlert https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795167/…
posted at 00:52:26
Naoto T Ueno, MD, PhD@teamoncology
Poor response to neoadjuvant chemotherapy correlates with mast cell infiltration in inflammatory breast cancer. You can now read the full article. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053657/… #bcsm #OncoAlert
posted at 00:50:45
Naoto T Ueno, MD, PhD@teamoncology
Outcome of my dogs haircut. All haircut is done at home due to pandemic. https://pic.twitter.com/TXcrdCyLOM
posted at 22:05:38
Naoto T Ueno, MD, PhD@teamoncology
Forbes magazine ranked @MDAndersonNews as a Best Employer for Women. We were ranked 54 overall.
I am just learned that our workforce is 68% female. That is incredible. Very happy to hear this news.
https://www.youtube.com/watch?v=d19DvXS2vjk…
posted at 21:16:13
Naoto T Ueno, MD, PhD@teamoncology
Eight different resistance mechanism of CDK 4/6 inhibitor discovered for HR+ HER2- metastatic breast cancer. https://cancerdiscovery.aacrjournals.org/content/early/2020/07/21/2159-8290.CD-19-1390…
posted at 02:10:58
Naoto T Ueno, MD, PhD@teamoncology
Dr. Lee presents Can't Touch This Covid Parody. 校長先生の粋な新型コロナウイルス対策ビデオ。https://youtu.be/oeAN8Xxz0q4 via @YouTube
posted at 08:27:51
Naoto T Ueno, MD, PhD@teamoncology
My dog getting a cut like a sheep. Thanks to the COVID-19. https://pic.twitter.com/kRp2uNj2vv
posted at 01:08:16
Naoto T Ueno, MD, PhD@teamoncology
7-eleven buys Speedway. Did you know that 7-eleven is a Japanese company? This is the largest buy out during the COVID-19 era. https://www.cnn.com/2020/08/03/business/speedway-7-eleven-marathon-deal-intl-hnk/index.html…
https://www.cnn.com/2020/08/03/business/speedway-7-eleven-marathon-deal-intl-hnk/index.html…
posted at 00:04:25
Naoto T Ueno, MD, PhD@teamoncology
Mask needs to cover both mouth and nose. Coronavirus can spread from nose or mouth. Both nose and mouth are connected to the lung. https://www.nbcdfw.com/news/health/leaving-your-nose-uncovered-defeats-the-purpose-of-wearing-a-mask/2412189/?amp… https://pic.twitter.com/W7Pha9kg1j
posted at 05:37:00
Naoto T Ueno, MD, PhD@teamoncology
A very good article from @CNN about why some people may have symptoms and the other being asymptomatic to COVID-19. Also, it discusses the implications of vaccine development. https://www.cnn.com/2020/08/02/health/gupta-coronavirus-t-cell-cross-reactivity-immunity-wellness/index.html…
posted at 00:50:11
Naoto T Ueno, MD, PhD@teamoncology
Please join this wonderful webinar about the International Panel Discussion Series now #Nurses, #Bioethics, and the responses to the #COVID19 Pandemic by @UNESCO UNESCO.
Aug 2, 2020, USA East 7.30 AM
Register in advance for this meeting:
https://us02web.zoom.us/meeting/register/tZEvf-CtrTkvGdXoKCyRYWT0IoKjrDRdt7mw…
posted at 04:25:50
Naoto T Ueno, MD, PhD@teamoncology
A picture of the damaged lung by #COVID19 COVID-19. The patient who is in the 20s underwent a double lung transplant. Happy for the success but the story is sad to know that she has to go through this endeavor. https://twitter.com/nuenojpn/status/1289196861425766403…
posted at 02:08:15
Naoto T Ueno, MD, PhD@teamoncology
KEYNOTE-522 approval results in the use of pembrolizumab in the neoadjuvant setting for newly diagnosed TNBC. Further, it will change the landscape of the recurrent metastatic TNBC because of previous exposure to immunotherapy. #bcsm #OncoAlert https://twitter.com/teamoncology/status/1289607314304053250…
posted at 02:06:19
Naoto T Ueno, MD, PhD@teamoncology
The PDUFA date refers to the date the FDA is expected to deliver its decision whether or not to approve a companies' New Drug Application (NDA) or Biologics License Application (BLA). #bcsm #OncoAlert
posted at 02:02:58
Naoto T Ueno, MD, PhD@teamoncology
A very important update for pembrolizumab (Keytruda) in triple-negative breast cancer. For KEYNOTE-355, the FDA has set a PDUFA, date of 11/28/20. For KEYNOTE-522, it is 03/29/21. We will find out yes or no before these days. #bcsm #OncoAlert
https://investors.merck.com/news/press-release-details/2020/Merck-Announces-Two-US-Regulatory-Milestones-for-KEYTRUDA-pembrolizumab-in-Triple-Negative-Breast-Cancer-TNBC/default.aspx…
posted at 02:01:58
Naoto T Ueno, MD, PhD@teamoncology
@OncoAlert @MDAndersonNews @weoncologists @VivekSubbiah @MDAndersonJobs @MDAndersonTrial @MDAndersonLib @MDAnderson_ES @Aiims1742 Thanks!!
posted at 02:28:26
Naoto T Ueno, MD, PhD@teamoncology
We often get a question about how does @MDAndersonNews @InflammatoryBCa treats the IBC patient? We now have an official treatment algorithm that we can share with the public. Please share. #endcancer #bcsm
https://www.mdanderson.org/content/dam/mdanderson/documents/for-physicians/algorithms/cancer-treatment/ca-%20treatment-breast-inflammatory-web-algorithm.pdf?fbclid=IwAR29nlo0H0yiMK4ffizPhRHe_jlRZDRaSEbbIyd24H7dS3UvDasyXgpCNws…
posted at 23:35:04
Naoto T Ueno, MD, PhD@teamoncology
Do you know the efficacy data of chemotherapy after receiving the CDK4/6 inhibitor? This paper based on the @MDAndersonNews breast cancer dataset will give some insight into which drug is optimal to choose. #bcsm #endcancer
https://link.springer.com/epdf/10.1007/s10549-020-05837-6?sharing_token=c_LWZb9s78EZA7vJiUrUy_e4RwlQNchNByi7wbcMAY7c6nGJq5cvlQE7zdbjA2vjW3atzZnRBMmPgaV8S0UuZIr10-LZCkDWKi1gN851pBwVw-cd3RcyDE9G_GTJGvWYu01n1IpdZagJq0E_pbvXXQMD8uit9etSBMQFK42BIXY%3D…
posted at 23:29:27
Naoto T Ueno, MD, PhD@teamoncology
MD Anderson Cancer Center (@MDAndersonNews) ranked as number 1 for the best hospital by @usnews. Congrats to all the employees and Alumni. I am very fortunate that I am working with great colleagues and staff.
https://health.usnews.com/best-hospitals/rankings/cancer…
posted at 23:08:07
Naoto T Ueno, MD, PhD@teamoncology
Please support the @BootWalk. I give cancer the boot for patients with IBC. Your donation will support the research related to inflammatory breast cancer. #endcancer #bcsm https://secure3.convio.net/mdacc/site/TR?fr_id=1341&pg=personal&px=1002116… https://pic.twitter.com/88qrMRqPSk
posted at 00:50:56
Naoto T Ueno, MD, PhD@teamoncology
Support for Stirling family who is my friend's daughter. https://www.gofundme.com/f/soldier-support-spc-stirling?utm_source=twitter&utm_medium=social&utm_campaign=m_pd+share-sheet…
posted at 00:43:05
Naoto T Ueno, MD, PhD@teamoncology
@curijoey Thank you ! I hope that you are staying safe.
posted at 00:47:06
Naoto T Ueno, MD, PhD@teamoncology
@HenrychihangFu1 @Haemophage Thank you !
posted at 00:46:50
Naoto T Ueno, MD, PhD@teamoncology
@BldCancerDoc @ASTCT Thank you !
posted at 00:46:41
Naoto T Ueno, MD, PhD@teamoncology
@kgapo Thank you for your support.
posted at 00:46:10
Naoto T Ueno, MD, PhD@teamoncology
Obesity and related conditions and risk of inflammatory breast cancer (IBC): a nested case-control study https://pubmed.ncbi.nlm.nih.gov/32691376/ #bcsm
posted at 00:45:43
Naoto T Ueno, MD, PhD@teamoncology
@JediPD Thanks!!
posted at 07:32:39
Naoto T Ueno, MD, PhD@teamoncology
@DrTurk6 Thank you very much for your support!
posted at 07:32:32
Naoto T Ueno, MD, PhD@teamoncology
@drkomanduri @ASTCT I wish that I can be a transplant doc for breast cancer. :) Thanks for your kind words.
posted at 07:31:31
Naoto T Ueno, MD, PhD@teamoncology
Tumor Microenvironment Remodeling Enables Bypass of Oncogenic KRAS Dependency in Pancreatic Cancer. A very important paper from @RonDePinho research group. A similar concept most likely applies to other cancer. https://cancerdiscovery.aacrjournals.org/content/10/7/1058…
posted at 05:27:41
Naoto T Ueno, MD, PhD@teamoncology
@drkomanduri @ASTCT Thanks!!!! Stay safe.
posted at 05:14:55
Naoto T Ueno, MD, PhD@teamoncology
I would like to thank you all the stem cell physicians & healthcare providers who serve the stem transplant team to save live. It takes a major dedication to keep the transplant patient alive. I feel the dedication and I myself know what it takes as an ex-SCT doc. @ASTCT https://twitter.com/drkomanduri/status/1286746987409412096…
posted at 05:14:36
Naoto T Ueno, MD, PhD@teamoncology
@Rndubois Congratulations for your new position!!
posted at 04:06:24
Naoto T Ueno, MD, PhD@teamoncology
@ACS_Research Thank you for your support.
posted at 04:06:09
Naoto T Ueno, MD, PhD@teamoncology
@JulieMeryl09 Thank you !! 10 years Wow. Congratulations to you also.
posted at 02:44:04
Naoto T Ueno, MD, PhD@teamoncology
Three years old today. No disease, no complications, full of energy after unrelated mismatch allogeneic SCT for MDS. I am alive because of the beautiful gift from a young male from Japan. He's my hero. All the stem cell donors are my hero. #endcancer https://pic.twitter.com/WeIxmLQKjP
posted at 02:14:44
